Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing
Michael Dolton, Andrew J. McLachlan(The University of Sydney), John E. Ray(St Vincent's Hospital Melbourne), Gerd Mikus(Heidelberg University)
Cited by 98
Related Papers
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
|Journal of Clinical Epidemiology|2012|1.2k
Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis
|BMJ Open|2016|527
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies
|Thrombosis and Haemostasis|2014|467
Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib
|Clinical Pharmacokinetics|2000|424